Scrip    Clinica    RAJ    Scrip Clinical Research    Animal Pharm   
Email ID
Password
Sign me in automatically next time
29 July 2010

The US Food and Drug Administration has given organisations until 3 September to apply for grants to develop new animal drugs intended for minor species or minor uses in major species 1 ,2 . The grants, established under US legislation, could range ...

29 April 2010

Kenya, Rwanda, Tanzania and Uganda in east Africa are planning to launch a new regional pharmaceutical industry trade association in June to help develop proposals for a possible common drug dossier for the four countries. ?With the harmonisation of ...

26 February 2010

The US Pharmacopeial Convention is expanding its Indian operations, buoyed by the growth of the Indian pharmaceutical sector and increased demand for its products and services. The USP is a non-profit scientific organisation that sets standards for ...

26 July 2010

Cough and cold medicines in New Zealand that contain dextromethorphan and phenylephrine will from 1 May 2011 no longer be sold in supermarkets for children under 12 years of age and will instead be sold in pharmacies only 1 . New Zealand's ...

22 July 2010

China and Taiwan have signed a wide-ranging bilateral agreement on the protection of intellectual property rights, which lays down major principles with implications for many products, including pharmaceuticals 1 . The Cross-Strait Agreement on IPR ...

29 July 2010

It's common knowledge that the US and European Union drug regulators often reach different conclusions as to whether a pharmaceutical product should be approved, withdrawn or restricted. Those differences have been thrown into even sharper relief by ...

29 July 2010

Civil servants at the Department of Health in London are quietly working on what may turn out to be a whole new pricing system for medicines in the UK following the publication of the coalition government's white paper on the National Health ...

28 July 2010

Vince Postill compares two anti-counterfeiting technologies and explains why mass serialisation may be the better solution. Whilst patients may be unaware about the true risk of drug counterfeiting, the pharmaceutical industry is far from ...

08 July 2010

The World Trade Organisation will hold a joint meeting on 16 July with the World Intellectual Property Organisation and the World Health Organisation to discuss how pricing and procurement can affect access to medicines 1 . The meeting, which will ...

13 May 2010

If the state of clinical research in South Africa continues on its current downward path, it will not be able to sustain ?solid research capacity in the clinical domain?, according to a report by the Academy of Science of South Africa 1 . The ...

28 April 2010

The branded pharmaceutical industry has criticised a decision by the government of Ecuador to grant a compulsory licence for the ritonavir component of Abbott?s combination antiretroviral Kaletra, saying it undermines the patent system 1 . The ...

29 July 2010

It's common knowledge that the US and European Union drug regulators often reach different conclusions as to whether a pharmaceutical product should be approved, withdrawn or restricted. Those differences have been thrown into even sharper relief by ...

29 July 2010

Michael Rosenberg explains how adaptive monitoring can be a better way of tracking investigative site quality and performance. You never thought it possible: the clinical trial under your organisation's management is coming under fire for ...

 
29 July 2010
Elizabeth Sukkar
Civil servants at the Department of Health in London are quietly working on what may turn out to be a whole new pricing system for medicines in the UK following the publication of the coalition government's white paper on the National Health ...
 
18 June 2010
Faraz Kermani
Juan García Burgos of the EMA tells Faraz Kermani about the expanding role of the patient in agency decisions. The European Medicines Agency has been interacting with patients, healthcare professionals, academia, the pharmaceutical industry and ...
 
29 July 2010
Michael Rosenberg explains how adaptive monitoring can be a better way of tracking investigative site quality and performance. You never thought it possible: the clinical trial under your organisation's management is coming under fire for ...
28 July 2010
Vince Postill compares two anti-counterfeiting technologies and explains why mass serialisation may be the better solution. Whilst patients may be unaware about the true risk of drug counterfeiting, the pharmaceutical industry is far from ...
27 July 2010
Alison Dennis urges pharmaceutical companies to review their compliance policies ahead of the Act's entry into force. The UK Bribery Act 2010, which became law in April 1 and is due to come into force in April 2011 2 , is long overdue. It replaces ...
 
08 October 2009
Please give details of the major acts and directives governing trademarks. Trademarks are governed in Luxembourg by the: Benelux Convention on ...
07 October 2009
Please give details of the major acts and directives governing trademarks Benelux Convention on Intellectual Property: Convention Benelux en matière ...
 
RAJ Pharma News Roundup, July 2010
19 July 2010
 
New Scottish appointment for ABPI The Association of the British Pharmaceutical Industry has appointed Sandra Auld to the new position of operations director in Scotland. The appointment is part of the association?s plans to strengthen its work as a key player in Scotland?s life ...
ISPE names North American regulatory affairs advisor The International Society for Pharmaceutical Engineering ( ISPE ), a not-for-profit association of 24,000 technical professionals working in pharmaceutical manufacturing and drug development, has named Anthony Celeste as its North America ...
 
   
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36